Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
07/25 GLAXOSMITHKLINE : World's first malaria vaccine close to launch
07/25 GLAXOSMITHKLINE : Malaria vaccine gets green light ; BRITAIN TODAY
07/24 Allergan said to be exploring split into two businesses - source
07/24 GLAXOSMITHKLINE : European medical body gives green light for malaria vaccine
07/24DJGlaxoSmithKline plc 2Q 2015 -- Forecast
07/24 GLAXOSMITHKLINE : Malaria Vaccine Gets Positive CHMP Opinion
07/24DJGlaxoSmithKline's Malaria Vaccine Clears Final Scientific Hurdle
07/24 GLAXOSMITHKLINE : GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S..
07/23 GLAXOSMITHKLINE : Dr James Shannon appointed to Immodulon Therapeutics Board of ..
07/22 GLAXOSMITHKLINE : TraceLink Expands Expertise with Former Industry Experts from ..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials